Astaxanthin as a potential neuroprotective agent for neurological diseases

184Citations
Citations of this article
169Readers
Mendeley users who have this article in their library.

Abstract

Neurological diseases, which consist of acute injuries and chronic neurodegeneration, are the leading causes of human death and disability. However, the pathophysiology of these diseases have not been fully elucidated, and effective treatments are still lacking. Astaxanthin, a member of the xanthophyll group, is a red-orange carotenoid with unique cell membrane actions and diverse biological activities. More importantly, there is evidence demonstrating that astaxanthin confers neuroprotective effects in experimental models of acute injuries, chronic neurodegenerative disorders, and neurological diseases. The beneficial effects of astaxanthin are linked to its oxidative, anti-inflammatory, and anti-apoptotic characteristics. In this review, we will focus on the neuroprotective properties of astaxanthin and explore the underlying mechanisms in the setting of neurological diseases.

Cite

CITATION STYLE

APA

Wu, H., Niu, H., Shao, A., Wu, C., Dixon, B. J., Zhang, J., … Wang, Y. (2015, September 1). Astaxanthin as a potential neuroprotective agent for neurological diseases. Marine Drugs. MDPI AG. https://doi.org/10.3390/md13095750

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free